References:
1. Nocturne, G. and X. Mariette, Advances in understanding the pathogenesis of primary Sjögren’s syndrome. Nat Rev Rheumatol, 2013.9 (9): p. 544-56.
2. Fox, R.I., Sjögren’s syndrome. Lancet, 2005.366 (9482): p. 321-31.
3. Emamian, E.S., et al., Peripheral blood gene expression profiling in Sjögren’s syndrome. Genes Immun, 2009. 10 (4): p. 285-96.
4. Kimoto, O., et al., Activation of the interferon pathway in peripheral blood of patients with Sjogren’s syndrome. J Rheumatol, 2011. 38 (2): p. 310-6.
5. Imgenberg-Kreuz, J., et al., Transcription profiling of peripheral B cells in antibody-positive primary Sjögren’s syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature. Scand J Immunol, 2018. 87 (5): p. e12662.
6. Inamo, J., et al., Identification of novel genes associated with dysregulation of B cells in patients with primary Sjögren’s syndrome. Arthritis Res Ther, 2020. 22 (1): p. 153.
7. Brkic, Z., et al., Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren’s syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis, 2013.72 (5): p. 728-35.
8. Peng, Y., et al., The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren’s syndrome. Arthritis Res Ther, 2022.24 (1): p. 170.
9. Gottenberg, J.E., et al., Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome. Proc Natl Acad Sci U S A, 2006. 103 (8): p. 2770-5.
10. Rivière, E., et al., Salivary gland epithelial cells from patients with Sjögren’s syndrome induce B-lymphocyte survival and activation. Ann Rheum Dis, 2020. 79 (11): p. 1468-1477.
11. Hall, J.C., et al., Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc Natl Acad Sci U S A, 2012. 109 (43): p. 17609-14.
12. Ittah, M., et al., B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren’s syndrome. Arthritis Res Ther, 2006. 8 (2): p. R51.
13. Ivashkiv, L.B. and L.T. Donlin, Regulation of type I interferon responses. Nat Rev Immunol, 2014. 14 (1): p. 36-49.
14. Reizis, B., Plasmacytoid Dendritic Cells: Development, Regulation, and Function. Immunity, 2019. 50 (1): p. 37-50.
15. Ah Kioon, M.D., et al., Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8. Sci Transl Med, 2018.10 (423).
16. Albanesi, C., et al., Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med, 2009. 206 (1): p. 249-58.
17. Nehmar, R., et al., Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental Arthritis. Arthritis Rheumatol, 2017.69 (11): p. 2124-2135.
18. Diana, J., et al., Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med, 2013. 19 (1): p. 65-73.
19. Maria, N.I., et al., Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren’s syndrome. Ann Rheum Dis, 2017. 76 (4): p. 721-730.
20. Vogelsang, P., et al., Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren’s syndrome. Ann Rheum Dis, 2010.69 (6): p. 1235-8.
21. Hillen, M.R., et al., Plasmacytoid DCs From Patients With Sjögren’s Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production. Front Immunol, 2019. 10 : p. 2096.
22. Shiboski, C.H., et al., 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis, 2017.76 (1): p. 9-16.
23. Hochberg, M.C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997. 40 (9): p. 1725.
24. Grzes, K.M., et al., Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters. Immunity, 2021. 54 (11): p. 2514-2530.e7.
25. Cella, M., et al., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med, 1999. 5 (8): p. 919-23.
26. Psarras, A., et al., Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity. Nat Commun, 2020. 11 (1): p. 6149.
27. Ittah, M., et al., Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways. Eur J Immunol, 2008. 38 (4): p. 1058-64.
28. Kyriakidis, N.C., et al., Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway. Clin Exp Immunol, 2014. 178 (3): p. 548-60.
29. Verstappen, G.M., et al., Epithelial-immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis. Nat Rev Rheumatol, 2021. 17 (6): p. 333-348.
30. Del Papa, N., et al., The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives.Biomolecules, 2021. 11 (2).
31. Marketos, N., et al., Type I interferon signature in Sjögren’s syndrome: pathophysiological and clinical implications. Clin Exp Rheumatol, 2019. 37 Suppl 118 (3): p. 185-191.
32. Tran, T.T.P., T.H. Tran, and E.J. Kremer, IgG-Complexed Adenoviruses Induce Human Plasmacytoid Dendritic Cell Activation and Apoptosis. Viruses, 2021. 13 (9).
33. Nocturne, G. and X. Mariette, B cells in the pathogenesis of primary Sjögren syndrome. Nat Rev Rheumatol, 2018. 14 (3): p. 133-145.
34. Jego, G., et al., Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.Immunity, 2003. 19 (2): p. 225-34.
35. Menon, M., et al., A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus. Immunity, 2016. 44 (3): p. 683-697.
36. Soni, C., et al., Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA. Immunity, 2020. 52 (6): p. 1022-1038.e7.
37. Schrezenmeier, E. and T. Dörner, Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol, 2020. 16 (3): p. 155-166.
38. Wang, X., et al., The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis. Front Pharmacol, 2021. 12 : p. 693796.
39. Colafrancesco, S., et al., Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren’s Syndrome. Arthritis Rheumatol, 2022. 74 (4): p. 654-664.
40. Barrera, M.J., et al., Salivary mucins induce a Toll-like receptor 4-mediated pro-inflammatory response in human submandibular salivary cells: are mucins involved in Sjögren’s syndrome? Rheumatology (Oxford), 2015. 54 (8): p. 1518-27.
41. Kafaja, S., et al., pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis. JCI Insight, 2018. 3 (9).
42. Arai, Y., et al., Plasmacytoid Dendritic Cell Activation and IFN-α Production Are Prominent Features of Murine Autoimmune Pancreatitis and Human IgG4-Related Autoimmune Pancreatitis. J Immunol, 2015. 195 (7): p. 3033-44.
43. Glitzner, E., et al., Specific roles for dendritic cell subsets during initiation and progression of psoriasis. EMBO Mol Med, 2014. 6 (10): p. 1312-27.
44. Blomberg, S., et al., Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus, 2001. 10 (7): p. 484-90.
45. Tucci, M., et al., Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18.Arthritis Rheum, 2008. 58 (1): p. 251-62.
46. Furie, R.A., et al., Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus. N Engl J Med, 2022. 387 (10): p. 894-904.
47. Ye, Y., et al., Plasmacytoid dendritic cell biology and its role in immune-mediated diseases. Clin Transl Immunology, 2020.9 (5): p. e1139.